iBio Inc (AMEX:IBIO) shares, rose in value, with the stock price up by 2.80% to the previous day’s close as strong demand from buyers drove the stock to $2.94.
Actively observing the price movement in the last trading, the stock closed the session at $2.86. The value of beta (5-year monthly) was -3.80. Referring to stock’s 52-week performance, its high was $42.20, and the low was $1.02. On the whole, IBIO has fluctuated by 135.20% over the past month.
With the market capitalization of iBio Inc currently standing at about $10.23 million, investors are eagerly awaiting this quarter’s results, scheduled for May 13, 2024 – May 17, 2024.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that IBIO’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Sell while long term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of IBIO currently trading nearly 85.52% and 119.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 66.99, while the 7-day volatility ratio is showing 35.60% which for the 30-day chart, stands at 11.81%. Furthermore, iBio Inc (IBIO)’s beta value is -3.46, and its average true range (ATR) is 0.42.
A comparison of iBio Inc (IBIO) with its peers suggests the former has fared considerably weaker in the market. IBIO showed an intraday change of 2.80% in last session, and over the past year, it shrunk by -92.93%%.
Data on historical trading for iBio Inc (AMEX:IBIO) indicates that the trading volumes over the past 10 days have averaged 23.08 million and over the past 3 months, they’ve averaged 3.78 million. According to company’s latest data on outstanding shares, there are 3.48 million shares outstanding.
Nearly 0.39% of iBio Inc’s shares belong to company insiders and institutional investors own 24.44% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 59320.0 shares as on Mar 15, 2024, resulting in a short ratio of 0.43. According to the data, the short interest in iBio Inc (IBIO) stood at 1.70% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 13990.0. The stock has risen by 114.60% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IBIO stock heading into the next quarter.
